These Popular Drugs Can Make You Violent – Avoid Them

Some medications have been linked to an increased risk for violent, even homicidal behavior. A recent study identified 31 drugs that are disproportionately linked with violent behavior. Time Magazine lists the top ten offenders:
1. Varenicline (Chantix): The number one violence-inducing drug on the list, this anti-smoking medication is 18 times more likely to be linked with violence when compared to other drugs
2. Fluoxetine (Prozac): This drug was the first well-known SSRI antidepressant
3. Paroxetine (Paxil): Another SSRI antidepressant, Paxil is also linked with severe withdrawal symptoms and a risk of birth defects
4. Amphetamines: (Various): Used to treat ADHD
5. Mefoquine (Lariam): A treatment for malaria which is often linked with reports of strange behavior
6. Atomoxetine (Strattera): An ADHD drug that affects the neurotransmitter noradrenaline
7. Triazolam (Halcion): This potentially addictive drug is used to treat insomnia
8. Fluvoxamine (Luvox): Another SSRI antidepressant
9. Venlafaxine (Effexor): An antidepressant also used to treat anxiety disorders
10. Desvenlafaxine (Pristiq): An antidepressant which affects both serotonin and noradrenalin

FDA Advisory Panel Recommends Electroshock Machine Too Risky For Reclassification to Less Dangerous Device

The Neurological Devices Advisory Panel of the U.S. Food and Drug Administration (F.D.A.), recommended Friday that devices used to deliver shock treatment, also known as electroconvulsive therapy (ECT) remain in the most high-risk category (Class III), reserved for the most dangerous medical devices and not be downgraded to a lower risk category. In so doing, it recommended that the companies which manufacture ECT devices be required to prove that ECT is both effective and safe in order to remain in use. ECT has long been known to cause serious harm to patients, including extremely severe and permanent memory loss, inability to learn and remember new events, depression, suicide, cardiovascular complications, prolonged and dangerous seizures and even death.

West Hollywood psychiatrist, states second largest prescriber of Schedule ll drugs, pleads guilty to illegal distribution of prescription drugs

A West Hollywood psychiatrist who operated a “pill mill,” in which thousands of prescriptions for addictive drugs were written for cash, pleaded guilty Thursday to a single charge of distribution of a controlled substance. Upon entering his plea, Dr. Nathan Kuemmerle, 38, of Hollywood, told U.S. District Judge Dolly M. Gee that he had recently completed treatment for drug addiction. Gee set an April 18 sentencing date for Kuemmerle, who faces a potential penalty of up to five years in federal prison, a fine of $250,000 and three years of supervised release, according to the U.S. Attorney’s Office.

Not the Only Psychiatrist Who Opposes ECT

by Dr. Peter Breggin—The FDA is proposing to move ECT from the high risk category to the medium risk category to avoid the necessity of any testing for safety or efficacy. As a result, ECT would be grandfathered into continued use without ever being tested. This would place ECT in the same category as syringes which no longer need proof of safety or efficacy. The FDA hearings will be held January 27-28, 2011, and I hope some of my more courageous colleagues will attend and testify against approving ECT without testing.
ECT causes closed head injury by means of electrically-induced seizures. There can be no doubt that the treatment causes trauma to the brain. The patient is comatose for several minutes in the recovery room and after a few treatments becomes confused and disoriented. A recent study confirms long-term memory loss and other cognitive deficits, which by definition is dementia. As I review in Brain-Disabling Treatments in Psychiatry (2008, pp. 237-241), large animal studies have shown brain cell death using ECT dosages less than those routinely inflicted today. My website has a very extensive ECT bibliography that can be downloaded for free. It includes a variety of the original large animal ECT research projects.

Drugs cloud US troops judgment

Experts believe the growing variety of antipsychotic drugs prescribed for the US combat forces impair the troops’ ability to make correct judgments.
The United States Central Command allows troops struggling with sleep deprivation to receive a 6-month supply of Seroquel — a drug first developed to treat schizophrenia, bipolar disorders, mania and depression, according to a report published by AllGov on Sunday.

SHARE YOUR STORY/COMMENT: